Cargando…
Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients
PURPOSE: Agonistic β2-adrenergic receptor autoantibodies (β2-agAAb) have been observed in sera of patients with ocular hypertension and open-angle glaucoma (OAG). They target the β2-receptors on trabecular meshwork, ciliary body and pericytes (Junemann et al. 2018; Hohberger et al. 2019). In additio...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104926/ https://www.ncbi.nlm.nih.gov/pubmed/33961631 http://dx.doi.org/10.1371/journal.pone.0249202 |
_version_ | 1783689512523661312 |
---|---|
author | Hohberger, Bettina Hosari, Sami Wallukat, Gerd Kunze, Rudolf Krebs, Johann Müller, Meike Hennig, Till Lämmer, Robert Horn, Folkert Muñoz, Luis E. Herrmann, Martin Mardin, Christian |
author_facet | Hohberger, Bettina Hosari, Sami Wallukat, Gerd Kunze, Rudolf Krebs, Johann Müller, Meike Hennig, Till Lämmer, Robert Horn, Folkert Muñoz, Luis E. Herrmann, Martin Mardin, Christian |
author_sort | Hohberger, Bettina |
collection | PubMed |
description | PURPOSE: Agonistic β2-adrenergic receptor autoantibodies (β2-agAAb) have been observed in sera of patients with ocular hypertension and open-angle glaucoma (OAG). They target the β2-receptors on trabecular meshwork, ciliary body and pericytes (Junemann et al. 2018; Hohberger et al. 2019). In addition to their influence on the intraocular pressure, an association to retinal microcirculation is discussed. This study aimed to investigate foveal avascular zone (FAZ) characteristics by en face OCT angiography (OCT-A) in glaucoma suspects and its relationship to β2-agAAb status in patients with OAG. MATERIAL AND METHODS: Thirty-four patients (28 OAG, 6 glaucoma suspects) underwent standardized, clinical examination including sensory testing as white-on-white perimetry (Octopus G1, mean defect, MD) and structural measures as retinal nerve fibre layer (RNFL) thickness, neuroretinal rim width (BMO-MRW), retinal ganglion cell layer (RGCL) thickness, and inner nuclear layer (INL) thickness with high-resolution OCT. FAZ characteristics were measured by OCT-A scans of superficial vascular plexus (SVP), intermediate capillary plexus (ICP), and deep capillary plexus (DCP). FAZ-R was calculated (area FAZ (SVP)/area FAZ (ICP)). Using cardiomyocyte bioassays we analysed serum samples for the presence of β2-agAAb. RESULTS: (I) Total mean FAZ area [mm(2)]: 0.34±0.16 (SVP), 0.24±0.12 (ICP), and 0.49±0.24 (DCP); mean FAZ-R 1.58±0.94. No correlation was seen for FAZ-R with MD, RNFL, BMO-MRW, RGCL thickness and INL thickness (p>0.05). (II) ß2-agAAb have been observed in 91% patients and showed no correlation with MD, RNFL, BMO-MRW, RGCL thickness and INL thickness (p>0.05). (III) FAZ-R correlated significantly with the β2-agAAb-induced increase of the beat rate of cardiomyocyte (p = 0.028). CONCLUSION: FAZ characteristics did not correlate with any glaucoma associated functional and morphometric follow-up parameter in the present cohort. However, level of β2-agAAb showed a significantly correlation with FAZ-ratio. We conclude that β2-agAAb might be a novel biomarker in glaucoma pathogenesis showing association to FAZ-ratio with OCT-A. |
format | Online Article Text |
id | pubmed-8104926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-81049262021-05-18 Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients Hohberger, Bettina Hosari, Sami Wallukat, Gerd Kunze, Rudolf Krebs, Johann Müller, Meike Hennig, Till Lämmer, Robert Horn, Folkert Muñoz, Luis E. Herrmann, Martin Mardin, Christian PLoS One Research Article PURPOSE: Agonistic β2-adrenergic receptor autoantibodies (β2-agAAb) have been observed in sera of patients with ocular hypertension and open-angle glaucoma (OAG). They target the β2-receptors on trabecular meshwork, ciliary body and pericytes (Junemann et al. 2018; Hohberger et al. 2019). In addition to their influence on the intraocular pressure, an association to retinal microcirculation is discussed. This study aimed to investigate foveal avascular zone (FAZ) characteristics by en face OCT angiography (OCT-A) in glaucoma suspects and its relationship to β2-agAAb status in patients with OAG. MATERIAL AND METHODS: Thirty-four patients (28 OAG, 6 glaucoma suspects) underwent standardized, clinical examination including sensory testing as white-on-white perimetry (Octopus G1, mean defect, MD) and structural measures as retinal nerve fibre layer (RNFL) thickness, neuroretinal rim width (BMO-MRW), retinal ganglion cell layer (RGCL) thickness, and inner nuclear layer (INL) thickness with high-resolution OCT. FAZ characteristics were measured by OCT-A scans of superficial vascular plexus (SVP), intermediate capillary plexus (ICP), and deep capillary plexus (DCP). FAZ-R was calculated (area FAZ (SVP)/area FAZ (ICP)). Using cardiomyocyte bioassays we analysed serum samples for the presence of β2-agAAb. RESULTS: (I) Total mean FAZ area [mm(2)]: 0.34±0.16 (SVP), 0.24±0.12 (ICP), and 0.49±0.24 (DCP); mean FAZ-R 1.58±0.94. No correlation was seen for FAZ-R with MD, RNFL, BMO-MRW, RGCL thickness and INL thickness (p>0.05). (II) ß2-agAAb have been observed in 91% patients and showed no correlation with MD, RNFL, BMO-MRW, RGCL thickness and INL thickness (p>0.05). (III) FAZ-R correlated significantly with the β2-agAAb-induced increase of the beat rate of cardiomyocyte (p = 0.028). CONCLUSION: FAZ characteristics did not correlate with any glaucoma associated functional and morphometric follow-up parameter in the present cohort. However, level of β2-agAAb showed a significantly correlation with FAZ-ratio. We conclude that β2-agAAb might be a novel biomarker in glaucoma pathogenesis showing association to FAZ-ratio with OCT-A. Public Library of Science 2021-05-07 /pmc/articles/PMC8104926/ /pubmed/33961631 http://dx.doi.org/10.1371/journal.pone.0249202 Text en © 2021 Hohberger et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Hohberger, Bettina Hosari, Sami Wallukat, Gerd Kunze, Rudolf Krebs, Johann Müller, Meike Hennig, Till Lämmer, Robert Horn, Folkert Muñoz, Luis E. Herrmann, Martin Mardin, Christian Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients |
title | Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients |
title_full | Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients |
title_fullStr | Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients |
title_full_unstemmed | Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients |
title_short | Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients |
title_sort | agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104926/ https://www.ncbi.nlm.nih.gov/pubmed/33961631 http://dx.doi.org/10.1371/journal.pone.0249202 |
work_keys_str_mv | AT hohbergerbettina agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients AT hosarisami agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients AT wallukatgerd agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients AT kunzerudolf agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients AT krebsjohann agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients AT mullermeike agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients AT hennigtill agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients AT lammerrobert agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients AT hornfolkert agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients AT munozluise agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients AT herrmannmartin agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients AT mardinchristian agonisticautoantibodiesagainstß2adrenergicreceptorinfluenceretinalmicrocirculationinglaucomasuspectsandpatients |